Jonathan B. Baell
0000-0003-2114-8242
Publication & Citation Trends
Publications
351 total
Biological Activity and Structural Biology of Current KAT6A Inhibitor Chemotypes
Cited by 0
Semantic Scholar
Electrochemical β-Lactam Probes for Rapid Detection of β-Lactamases: From Solution-Phase Activation toward Surface-Integrated Biosensing.
Cited by 0
Semantic Scholar
Discovery of APO-50815, a Potent WEE1 Kinase Inhibitor with Exceptional Efficacy against Patient-Derived Colorectal Cancer Organoids
Cited by 0
Semantic Scholar
Unlocking pH-responsive dual payload release through hydrazone linkage chemistry.
Cited by 6
Semantic Scholar
Promiscuously bioactive compounds are prevalent in widely used commercial drug repurposing libraries.
Cited by 1
Semantic Scholar
Discovery of WEE1 Kinase Inhibitors with Potent Activity against Patient-Derived, Metastatic Colorectal Cancer Organoids.
Cited by 2
Semantic Scholar
Nitroreductase-Activated Probes for Monitoring Hypoxia.
Cited by 2
Semantic Scholar
Development of potent glutathione transferase Omega-1 inhibitors with applications in inflammation and cancer therapy.
Cited by 1
Semantic Scholar
Research Topics
Crystallization and Solubility Studies
(38)
X-ray Diffraction in Crystallography
(37)
Computational Drug Discovery Methods
(36)
Trypanosoma species research and implications
(29)
Chemical Synthesis and Analysis
(24)
Affiliations
Ningbo University
University of North Carolina at Chapel Hill
Novartis (Switzerland)
Commonwealth Scientific and Industrial Research Organisation
The Royal Melbourne Hospital